Billionaire Stephen Mandel Bought In To Verisign

LONE PINE CAPITALLone Pine Capital has recently filed a 13G with the SEC to announce that it has acquired 8.6 million shares of Verisign Inc (NASDAQ:VRSN), the Internet registry service that includes .com domain names. Based on the company’s share count, Lone Pine owns 5.5% of the shares outstanding, triggering the filing. Lone Pine is managed by billionaire Stephen Mandel, a Tiger Cub who now manages about $17 billion and has a personal wealth of about a tenth that figure. His investments have tended to significantly outperform the S&P 500 (see Stephen Mandel’s favorite stocks).

Mandel isn’t the only hedge fund manager to take an interest in Verisign, and not the only Tiger Cub either: at the end of June John Griffin’s Blue Ridge Capital reported a position of 6.2 million shares. Griffin was legendary investor Julian Robertson’s second in command before founding Blue Ridge in 1996. The fund increased its Verisign stake by 61% during the second quarter according to 13F filings (find more stock picks from Blue Ridge Capital). Philippe Laffont’s Coatue Management initiated a position of 1.3 million shares; Laffont is a Tiger Cub as well (see other stocks in Coatue’s portfolio). Point State Capital, managed by Sean Cullinan and other former portfolio managers at Stanley Druckenmiller’s Duquesne Capital, increased its own position by 74% between April and June to a total of 2.7 million shares.

The company delivered what these hedge funds were expecting when it announced its second quarter results. After failing to meet analyst expectations for two quarters in a row, Verisign grew its revenue by 13% compared to the second quarter of 2011. It also reported a $68 million gain in place of last year’s $11 million net loss. Over the first half of 2012, the company has increased its revenue by 13% and its net income by over $100 million (to $136 million). Cash flow from operations more than doubled in the first half of the year as well compared to the same period in 2011. This growth has been partly driven by an increase in domain names (up 8% for .com and .net domain names) as well as higher registration prices. On a geographic basis, revenue is up by a double-digit rate in the core U.S. market as well as in EMEA and APAC.

Verisign’s valuation multiples are high, suggesting that Mandel and other investors anticipate strong earnings growth to continue. The trailing price-to-earnings multiple is 31 with a forward P/E of 21. This seems a bit high priced to us; we can see the quantity of domain names continuing to increase in the future but are skeptical that Verisign will be able to get as much sustainable growth from pricing increases as it did in the second quarter.

As far as providing Internet infrastructure, we would look at Verisign alongside Oracle Corporation (NASDAQ:ORCL) and F5 Networks Inc (NASDAQ:FFIV). Oracle provides a number of products including database software and software development solutions (such as Java). Oracle’s low recent growth is expected by the sell-side to pick up and it trades at 11 times forward earnings estimates, though its trailing P/E is 16. Looking out further, its five-year PEG of 1 is well below Verisign’s of 1.7. F5 Networks Inc (NASDAQ:FFIV)provides networking technology for application delivery over the Internet, and has a valuation profile similar to Verisign’s: it trades at trailing and forward P/E multiples of 30 and 20, respectively. However, we would note that Verisign’s particularly high market share gives it a unique advantage over other companies in the technology sector, and perhaps it deserves a high multiple on that alone. This market share is protected by agreements with the Internet Corporation for Assigned Names and Numbers (ICANN) over many .com and .net domains for the next six years, and could certainly be renewed at that time as it was earlier this year. Therefore, the company should be able to preserve its margins as it grows safe from competition. Based on that strength we would take it over F5 Networks, and could possibly see it as being a better value than Oracle Corporation (NASDAQ:ORCL) due to the strength of Verisign’s “moat.”

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!